AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

AZD5153 is to be taken as oral capsules once or twice per day each day in 21 day cycles. Dosing will continue until disease progression or other study discontinuation criteria are met.

Olaparib, 300 mg, will be taken BID as oral capsules.